Clinical trial
Evaluation of the Onset and Duration of Action of Bepotastine Besilate…
NCT00424398 · Bausch & Lomb Incorporated, Industry · Completed
Key facts
| NCT number | NCT00424398 |
|---|---|
| Title | Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis |
| Official title | A Single-Center, Double-Masked, Randomized, Placebo-Controlled, Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis |
| Lead sponsor | Bausch & Lomb Incorporated, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Conjunctivitis, Allergic |
| Intervention type | Drug |
| Interventions | Bepreve, Placebo, Bepotastine Besilate |
| Enrollment | 107 |
| Start date | Feb 1, 2007 |
| Primary completion | Jul 1, 2007 |
| First posted | Jan 19, 2007 |
| Last update posted | Feb 15, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: